Advances and Challenges in the Management of Acute Colonic Pseudo-Obstruction (Ogilvie Syndrome)

Abstract

Although acute colonic pseudo-obstruction (ACPO), also known as Ogilvie syndrome, is a well-known clinical entity, in many respects it remains poorly understood and continues to challenge physicians and surgeons alike. Our understanding of ACPO continues to evolve and its epidemiology has changed as new conditions have been identified predisposing to ACPO with critical illness providing the common thread among them. A physician must keep ACPO high in the list of differential diagnoses when dealing with the patient experiencing abdominal distention, and one must be prepared to employ and interpret imaging studies to exclude mechanical obstruction. Rapid diagnosis is the key, and institution of conservative measures often will lead to resolution. Fortunately, when this fails pharmacologic intervention with neostigmine often proves effective. However, it is not a panacea: consensus on dosing does not exist, administration techniques vary and may impact efficacy, contraindications limit its use, and persistence and or recurrence of ACPO mandate continued search for additional medical therapies. When medical therapy fails or is contraindicated, endoscopy offers effective intervention with advanced techniques such as decompression tubes or percutaneous endoscopic cecostomy providing effective results. Operative intervention remains the treatment of last resort; surgical outcomes are associated with significant morbidity and mortality. Therefore, a surgeon should be aware of all options for decompression—conservative, pharmacologic, and endoscopic—and use them in best combination to the advantage of patients who often suffer from significant concurrent illnesses making them poor operative candidates.

Keywords

acute colonic pseudo-obstruction - ogilvie syndrome

• References

• 1 Ogilvie H. Large-intestine colic due to sympathetic deprivation; a new clinical syndrome. BMJ 1948; 2 (4579) 671-673
• 2 Dudley HAF, Paterson-Brown S. Pseudo-obstruction. Br Med J (Clin Res Ed) 1986; 292 (6529) 1157-1158
• 3 Dudley HAF, Sinclair IS, McLaren IF, McNair TJ, Newsam JE. Intestinal pseudo-obstruction. J R Coll Surg Edinb 1958; 3 (3) 206-217
• 4 Nanni G, Garbini A, Luchetti P, Nanni G, Ronconi P, Castagneto M. Ogilvie's syndrome (acute colonic pseudo-obstruction): review of the literature (October 1948 to March 1980) and report of four additional cases. Dis Colon Rectum 1982; 25 (2) 157-166
• 5 Rex DK. Colonoscopy and acute colonic pseudo-obstruction. Gastrointest Endosc Clin N Am 1997; 7 (3) 499-508
• 6 Jeffcoate WJ. Should eponyms be actively detached from diseases?. Lancet 2006; 367 (9519) 1296-1297
• 7 Barrett KE. Intestinal motility. In: Barrett KE, , ed. Gastrointestinal Physiology. New York, NY: McGraw-Hill; 2006: 154-158
• 8 Durai R. Colonic pseudo-obstruction. Singapore Med J 2009; 50 (3) 237-244
• 9 Vanderwinden J-M. Role of interstitial cells of Cajal and their relationship with the enteric nervous system. Eur J Morphol 1999; 37 (4-5) 250-256
• 10 Jain D, Moussa K, Tandon M, Culpepper-Morgan J, Proctor DD. Role of interstitial cells of Cajal in motility disorders of the bowel. Am J Gastroenterol 2003; 98 (3) 618-624
• 11 Mourelle M, Vilaseca J, Guarner F, Salas A, Malagelada JR. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol 1996; 270 (3 Pt 1) G425-G430
• 12 Akiho H, Ihara E, Motomura Y, Nakamura K. Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol 2011; 2 (5) 72-81
• 13 Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases. Dis Colon Rectum 1986; 29 (3) 203-210
• 14 Kahi CJ, Rex DK. Bowel obstruction and pseudo-obstruction. Gastroenterol Clin North Am 2003; 32 (4) 1229-1247
• 15 Kaiser AM. Ogilvie transition to colonic perforation. Am J Surg 2010; 200 (1) e15-e16
• 16 Davis L, Lowman RM. An evaluation of cecal size in impending perforation of the cecum. Surg Gynecol Obstet 1956; 103 (6) 711-718
• 17 Saunders MD, Kimmey MB. Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther 2005; 22 (10) 917-925
• 18 Godfrey EM, Addley HC, Shaw AS. The use of computed tomography in the detection and characterisation of large bowel obstruction. N Z Med J 2009; 122 (1305) 57-73
• 19 Jacob SE, Lee SH, Hill J. The demise of the instant/unprepared contrast enema in large bowel obstruction. Colorectal Dis 2008; 10 (7) 729-731
• 20 Schermer CR, Hanosh JJ, Davis M, Pitcher DE. Ogilvie's syndrome in the surgical patient: a new therapeutic modality. J Gastrointest Surg 1999; 3 (2) 173-177
• 21 Wegener M, Börsch G. Acute colonic pseudo-obstruction (Ogilvie's syndrome). Presentation of 14 of our own cases and analysis of 1027 cases reported in the literature. Surg Endosc 1987; 1 (3) 169-174
• 22 Beattie GC, Peters RT, Guy S, Mendelson RM. Computed tomography in the assessment of suspected large bowel obstruction. ANZ J Surg 2007; 77 (3) 160-165
• 23 Choi JS, Lim JS, Kim H , et al. Colonic pseudoobstruction: CT findings. AJR Am J Roentgenol 2008; 190 (6) 1521-1526
• 24 De Giorgio R, Knowles CH. Acute colonic pseudo-obstruction. Br J Surg 2009; 96 (3) 229-239
• 25 Harrison ME, Anderson MA, Appalaneni V , et al; ASGE Standards of Practice Committee. The role of endoscopy in the management of patients with known and suspected colonic obstruction and pseudo-obstruction. Gastrointest Endosc 2010; 71 (4) 669-679
• 26 Bonacini M, Smith OJ, Pritchard T. Erythromycin as therapy for acute colonic pseudo-obstruction (Ogilvie's syndrome). J Clin Gastroenterol 1991; 13 (4) 475-476
• 27 Lipton AB, Knauer CM. Pseudo-obstruction of the bowel. Therapeutic trial of metoclopramide. Am J Dig Dis 1977; 22 (3) 263-265
• 28 Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004; 19 (6) 687-694
• 29 Hutchinson R, Griffiths C. Acute colonic pseudo-obstruction: a pharmacological approach. Ann R Coll Surg Engl 1992; 74 (5) 364-367
• 30 Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999; 341 (3) 137-141
• 31 van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, Bosman RJ, Zandstra DF. Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure—a prospective, double-blind, placebo-controlled trial. Intensive Care Med 2001; 27 (5) 822-827
• 32 Amaro R, Rogers AI. Neostigmine infusion: new standard of care for acute colonic pseudo-obstruction?. Am J Gastroenterol 2000; 95 (1) 304-305
• 33 Stephenson BM, Morgan AR, Salaman JR, Wheeler MH. Ogilvie's syndrome: a new approach to an old problem. Dis Colon Rectum 1995; 38 (4) 424-427
• 34 Mehta R, John A, Nair P , et al. Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study. J Gastroenterol Hepatol 2006; 21 (2) 459-461
• 35 Trevisani GT, Hyman NH, Church JM. Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction. Dis Colon Rectum 2000; 43 (5) 599-603
• 36 White L, Sandhu G. Continuous neostigmine infusion versus bolus neostigmine in refractory Ogilvie syndrome. Am J Emerg Med 2011; 29 (5) 576 , e1–e3
• 37 Paran H, Silverberg D, Mayo A, Shwartz I, Neufeld D, Freund U. Treatment of acute colonic pseudo-obstruction with neostigmine. J Am Coll Surg 2000; 190 (3) 315-318
• 38 Sgouros SN, Vlachogiannakos J, Vassiliadis K , et al. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut 2006; 55 (5) 638-642
• 39 O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis 2010; 12 (6) 540-548
• 40 Maggi L, Mantegazza R. Treatment of myasthenia gravis: focus on pyridostigmine. Clin Drug Investig 2011; 31 (10) 691-701
• 41 Thomas J, Karver S, Cooney GA , et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358 (22) 2332-2343
• 42 Weinstock LB, Chang AC. Methylnaltrexone for treatment of acute colonic pseudo-obstruction. J Clin Gastroenterol 2011; 45 (10) 883-884
• 43 Holzer P. Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects. Curr Opin Anaesthesiol 2010; 23 (5) 616-622
• 44 Gonenne J, Camilleri M, Ferber I , et al. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol 2005; 3 (8) 784-791
• 45 Kukora JS, Dent TL. Colonoscopic decompression of massive nonobstructive cecal dilation. Arch Surg 1977; 112 (4) 512-517
• 46 Geller A, Petersen BT, Gostout CJ. Endoscopic decompression for acute colonic pseudo-obstruction. Gastrointest Endosc 1996; 44 (2) 144-150
• 47 Baraza W, Brown S, McAlindon M, Hurlstone P. Prospective analysis of percutaneous endoscopic colostomy at a tertiary referral centre. Br J Surg 2007; 94 (11) 1415-1420
• 48 Lynch CR, Jones RG, Hilden K, Wills JC, Fang JC. Percutaneous endoscopic cecostomy in adults: a case series. Gastrointest Endosc 2006; 64 (2) 279-282
• 49 Bertolini D, De Saussure P, Chilcott M, Girardin M, Dumonceau JM. Severe delayed complication after percutaneous endoscopic colostomy for chronic intestinal pseudo-obstruction: a case report and review of the literature. World J Gastroenterol 2007; 13 (15) 2255-2257
• 50 Uno Y. Introducer method of percutaneous endoscopic cecostomy and antegrade continence enema by use of the Chait Trapdoor cecostomy catheter in patients with adult neurogenic bowel. Gastrointest Endosc 2006; 63 (4) 666-673
• 51 Brown AS, Mueller PR, Ferrucci Jr JT. Controlled percutaneous gastrostomy: nylon T-fastener for fixation of the anterior gastric wall. Radiology 1986; 158 (2) 543-545
• 52 vanSonnenberg E, Varney RR, Casola G , et al. Percutaneous cecostomy for Ogilvie syndrome: laboratory observations and clinical experience. Radiology 1990; 175 (3) 679-682
• 53 Crass JR, Simmons RL, Frick MP, Maile CW. Percutaneous decompression of the colon using CT guidance in Ogilvie syndrome. AJR Am J Roentgenol 1985; 144 (3) 475-476
• 54 Maloney N, Vargas HD. Acute intestinal pseudo-obstruction (Ogilvie's syndrome). Clin Colon Rectal Surg 2005; 18 (2) 96-101
• 55 Duh Q-Y, Way LW. Diagnostic laparoscopy and laparoscopic cecostomy for colonic pseudo-obstruction. Dis Colon Rectum 1993; 36 (1) 65-70
• 56 Bullard KM, Dunn RD. Colon, rectum, and anus. In: Brunicardi FCAD, Billiar TR, Dunn DL, Hunter JG, Matthews JB, Pollock RE, , eds. Schwartz's Principles of Surgery. 9th ed. New York: McGraw-Hill; 2010: 1058
• 57 Theodoropoulou A, Koutroubakis IE. Ischemic colitis: clinical practice in diagnosis and treatment. World J Gastroenterol 2008; 14 (48) 7302-7308